Recent Company News

• 05:37 PM ET Apr 03, 2025
  

  HSBC downgrades Shanghai Pharmaceuticals to hold from buy

• 03:39 AM ET Apr 28, 2025
  

  Shanghai Pharmaceuticals Holding reports Q1 net income attributable CNY1.33B vs FactSet CNY1.57B [1 est] (HK$10.68, -0.10)

• 10:00 AM ET Apr 27, 2025
  

  Shanghai Pharmaceuticals Holding completes previously announces share transfer agreement with Hutchmed (HK$10.78, 0.00)

• 04:50 AM ET Apr 25, 2025
  

  Shanghai Pharmaceuticals Holding releases 2024 sustainability report (HK$10.78, 0.00)

• 05:21 AM ET Apr 22, 2025
  

  Shanghai Pharmaceuticals Holding receives FDA's ANDA approval for Valganciclovir Hydrochloride tablet (HK$10.86, 0.00)

• 08:42 AM ET Mar 27, 2025
  

  Shanghai Pharmaceuticals Holding reports FY net income attributable CNY4.55B vs FactSet CNY4.91B [14 est, CNY4.34-5.22B] (HK$11.66, 0.00)

• 07:31 AM ET Mar 21, 2025
  

  Shanghai Pharmaceuticals Holding's subsidiary fined and forfeited CNY165.8M (HK$11.70, 0.00)

• 06:06 AM ET Mar 17, 2025
  

  Shanghai Pharmaceuticals Holding initiated recommend at Ping An Securities (timing uncertain) (CNY 19.26, 0.00)

• 10:35 PM ET Feb 05, 2025
  

  StreetAccount Summary - Trading higher/lower: China mid-morning